Intermittent Hypoxia Regulates Stem-like Characteristics and Differentiation of Neuroblastoma Cells

Background Neuroblastomas are the most common extracranial solid tumors in children. Neuroblastomas are derived from immature cells of the sympathetic nervous system and are characterized by clinical and biological heterogeneity. Hypoxia has been linked to tumor progression and increased malignancy. Intermittent hypoxia or repeated episodes of hypoxia followed by re-oxygenation is a common phenomenon in solid tumors including neuroblastoma and it has a significant influence on the outcome of therapies. The present study focuses on how intermittent hypoxia modulates the stem-like properties and differentiation in neuroblastoma cells. Methods and Findings Cell survival was assessed by clonogenic assay and cell differentiation was determined by morphological characterization. Hypoxia-inducible genes were analyzed by real-time PCR and Western blotting. Immunofluorescence, real-time PCR and Western blotting were utilized to study stem cell markers. Analysis of neural crest / sympathetic nervous system (SNS) markers and neuronal differentiation markers were done by real-time PCR and Western blotting, respectively. Intermittent hypoxia stimulated the levels of HIF-1α and HIF-2 α proteins and enhanced stem-like properties of neuroblastoma cells. In intermittent hypoxia-conditioned cells, downregulation of SNS marker genes and upregulation of genes expressed in the neural crest were observed. Intermittent hypoxia suppressed the retinoic acid-induced differentiation of neuroblastoma cells. Conclusions Our results suggest that intermittent hypoxia enhances stem-like characteristics and suppresses differentiation propensities in neuroblastoma cells.

[1]  Lesley A. Mathews,et al.  The cancer stem cell niche—there goes the neighborhood? , 2011, International journal of cancer.

[2]  G. Semenza.  Oxygen sensing, homeostasis, and disease. , 2011, The New England journal of medicine.

[3]  M. Cleary,et al.  HIF induces human embryonic stem cell markers in cancer cells. , 2011, Cancer research.

[4]  C. Hsieh,et al.  Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity. , 2010, Oncology reports.

[5]  E. Chen,et al.  Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation , 2010, Breast Cancer Research.

[6]  W. Wong,et al.  Hypoxia-inducible factors and the response to hypoxic stress. , 2010, Molecular cell.

[7]  Xianrang Song,et al.  Effect of chronic intermittent hypoxia on biological behavior and hypoxia‐associated gene expression in lung cancer cells , 2010, Journal of cellular biochemistry.

[8]  E. Rofstad,et al.  Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination , 2010, International journal of cancer.

[9]  H. Juan,et al.  Notch1 Expression Predicts an Unfavorable Prognosis and Serves as a Therapeutic Target of Patients with Neuroblastoma , 2010, Clinical Cancer Research.

[10]  Paola De Rosa,et al.  The Physiological Behaviour of IMR-32 Neuroblastoma Cells is Affected by a 12-h Hypoxia/24-h Reoxygenation Period , 2010, Neurochemical Research.

[11]  Frank Rose,et al.  HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. , 2010, Free radical biology & medicine.

[12]  J. Heymach,et al.  Multiple receptor tyrosine kinases regulate HIF-1α and HIF-2α in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors , 2010, Oncogene.

[13]  R. Boidot,et al.  Identification of Cyclooxygenase-2 as a Major Actor of the Transcriptomic Adaptation of Endothelial and Tumor Cells to Cyclic Hypoxia: Effect on Angiogenesis and Metastases , 2010, Clinical Cancer Research.

[14]  D. Zelterman,et al.  Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity. , 2009, Cancer research.

[15]  Jianjun Tang,et al.  Hypoxia‐inducible factor‐1α blocks differentiation of malignant gliomas , 2009, The FEBS journal.

[16]  J. Engh,et al.  Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α , 2009, Oncogene.

[17]  Donna D. Zhang,et al.  Nrf2 promotes neuronal cell differentiation. , 2009, Free radical biology & medicine.

[18]  Hui Wang,et al.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.

[19]  R. Hill,et al.  Increased expression of metastasis-related genes in hypoxic cells sorted from cervical and lymph nodal xenograft tumors , 2009, Laboratory Investigation.

[20]  R. Ezhilarasan,et al.  The hemopexin domain of MMP‐9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice , 2009, International journal of cancer.

[21]  Shi-wang Li,et al.  Expression and clinical significance of stem cell marker CD133 in human neuroblastoma , 2008, World journal of pediatrics : WJP.

[22]  G. Koren,et al.  Hypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction , 2008, Stem cells.

[23]  C. Michiels,et al.  Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours , 2008, The FEBS journal.

[24]  Mark W. Dewhirst,et al.  Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response , 2008, Nature Reviews Cancer.

[25]  D. Gisselsson,et al.  High levels of HIF‐2α highlight an immature neural crest‐like neuroblastoma cell cohort located in a perivascular niche , 2007, The Journal of pathology.

[26]  M. Raes,et al.  Intermittent hypoxia changes HIF-1α phosphorylation pattern in endothelial cells: Unravelling of a new PKA-dependent regulation of HIF-1α , 2007 .

[27]  Jing-kun Pan,et al.  Heterogeneity in retinoic acid signaling in neuroblastomas: Role of matrix metalloproteinases in retinoic acid-induced differentiation. , 2007, Biochimica et biophysica acta.

[28]  R. Ross,et al.  Human neuroblastoma stem cells. , 2007, Seminars in cancer biology.

[29]  Mark W. Dewhirst,et al.  Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment , 2007, Cancer and Metastasis Reviews.

[30]  M. Dewhirst.  Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. , 2007, Cancer research.

[31]  V. Grégoire,et al.  Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. , 2006, Cancer research.

[32]  W. Weiss,et al.  Childhood tumors of the nervous system as disorders of normal development , 2006, Current opinion in pediatrics.

[33]  Å. Borg,et al.  Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. , 2006, Cancer cell.

[34]  U. Lendahl,et al.  Hypoxia requires notch signaling to maintain the undifferentiated cell state. , 2005, Developmental cell.

[35]  S. Påhlman,et al.  Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells , 2005, International journal of cancer.

[36]  E. Fredlund,et al.  Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors. , 2005, Seminars in cell & developmental biology.

[37]  John M Maris,et al.  The biologic basis for neuroblastoma heterogeneity and risk stratification , 2005, Current opinion in pediatrics.

[38]  C. Belka,et al.  Cyclic exposure to hypoxia and reoxygenation selects for tumor cells with defects in mitochondrial apoptotic pathways , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  L. Poellinger,et al.  Induction of ID2 Expression by Hypoxia-inducible Factor-1 , 2004, Journal of Biological Chemistry.

[40]  Z. Dong,et al.  Hypoxia Selection of Death-resistant Cells , 2004, Journal of Biological Chemistry.

[41]  Rakesh K. Jain,et al.  Pathology: Cancer cells compress intratumour vessels , 2004, Nature.

[42]  L. Poellinger,et al.  Hypoxia-induced dedifferentiation in neuroblastoma cells. , 2003, Cancer letters.

[43]  Rakesh K Jain,et al.  Molecular regulation of vessel maturation , 2003, Nature Medicine.

[44]  G. Brodeur.  Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.

[45]  L. Poellinger,et al.  Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Jackson,et al.  Reactive species mechanisms of cellular hypoxia-reoxygenation injury. , 2002, American journal of physiology. Cell physiology.

[47]  R. Hill,et al.  Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. , 2001, Cancer research.

[48]  C. Reynolds,et al.  Retinoid therapy of childhood cancer. , 2001, Hematology/oncology clinics of North America.

[49]  Ralph E. Durand, Christina Aquino-Parsons.  Clinical Relevance of Intermittent Tumour Blood Flow , 2001, Acta oncologica.

[50]  Raphael Kopan,et al.  Notch signaling: from the outside in. , 2000, Developmental biology.

[51]  H. Axelson,et al.  Induced neuroblastoma cell differentiation, associated with transient HES‐1 activity and reduced HASH‐1 expression, is inhibited by Notch1 , 2000, International journal of cancer.

[52]  G. Semenza,et al.  Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression , 2000, Critical reviews in biochemistry and molecular biology.

[53]  P. Houghton,et al.  Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts. , 1998, Journal of the National Cancer Institute.

[54]  David E. Housman,et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.

[55]  G. Semenza.  mechanisms of disease Oxygen Sensing , Homeostasis , and Disease , 2011 .

[56]  O. Feron,et al.  Intermittent hypoxia changes HIF-1alpha phosphorylation pattern in endothelial cells: unravelling of a new PKA-dependent regulation of HIF-1alpha. , 2007, Biochimica et biophysica acta.

[57]  S. Påhlman,et al.  Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models. , 2006, Advances in experimental medicine and biology.

[58]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[59]  K. Matthay,et al.  Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. , 1999, The New England journal of medicine.

[60]  J. Houghton,et al.  Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status. , 1998, Oncology research.